157 related articles for article (PubMed ID: 9332493)
1. MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas.
Mochen C; Giardini R; Costa A; Silvestrini R
Cell Prolif; 1997 Jan; 30(1):37-47. PubMed ID: 9332493
[TBL] [Abstract][Full Text] [Related]
2. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
3. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
[TBL] [Abstract][Full Text] [Related]
4. Contribution of 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma.
Costa A; Silvestrini R; Giardini R; Messina-Gabrielli G; Boracchi P; Veneroni S
Br J Cancer; 1992 Oct; 66(4):680-4. PubMed ID: 1419606
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
[TBL] [Abstract][Full Text] [Related]
6. Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non-Hodgkin's lymphomas.
Schmitt F; Tani E; Tribukait B; Skoog L
Cytopathology; 1999 Apr; 10(2):87-96. PubMed ID: 10211614
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Ki 67 proliferative index with clinical and pathological features on tissue sections of non Hodgkins lymphoma by immunostaining.
Naz E; Mirza T; Aziz S; Ali A; Danish F
J Pak Med Assoc; 2011 Aug; 61(8):748-52. PubMed ID: 22355994
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of DNA topoisomerase IIalpha expression provides independent prognostic information in non-Hodgkin's lymphomas.
Korkolopoulou P; Angelopoulou M; Siakantari M; Mitropoulos F; Vassilakopoulos T; Zorzos H; Rassidakis G; Androulaki A; Patsouris E; Kittas C; Davaris P; Pangalis GA
Histopathology; 2001 Jan; 38(1):45-53. PubMed ID: 11135046
[TBL] [Abstract][Full Text] [Related]
10. 'Aggressive' low grade lymphocytic lymphomas can be identified by flow cytometric S-phase determinations.
Lindh J; Jonsson H; Lenner P; Roos G
Hematol Oncol; 1992; 10(3-4):171-9. PubMed ID: 1398513
[TBL] [Abstract][Full Text] [Related]
11. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
[TBL] [Abstract][Full Text] [Related]
12. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers.
Holte H; Suo Z; Smeland EB; Kvaløy S; Langholm R; Stokke T
Acta Oncol; 1999; 38(4):495-503. PubMed ID: 10418718
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of apoptotic cell death in non-Hodgkin's lymphomas: a multivariate survival analysis including Ki67 and p53 oncoprotein expression.
Korkolopoulou P; Angelopoulou MK; Kontopidou F; Tsenga A; Patsouris E; Thomas-Tsagli E; Kittas C; Pangalis GA
Histopathology; 1998 Sep; 33(3):240-7. PubMed ID: 9777390
[TBL] [Abstract][Full Text] [Related]
15. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
[TBL] [Abstract][Full Text] [Related]
16. MIB-1 labelling index is an independent prognostic marker in primary breast cancer.
Jansen RL; Hupperets PS; Arends JW; Joosten-Achjanie SR; Volovics A; Schouten HC; Hillen HF
Br J Cancer; 1998 Aug; 78(4):460-5. PubMed ID: 9716027
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
[TBL] [Abstract][Full Text] [Related]
18. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
[TBL] [Abstract][Full Text] [Related]
19. S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.
Witzig TE; Habermann TM; Kurtin PJ; Schroeder G; Stenson MJ; Greipp PR
Cancer; 1995 Sep; 76(6):1059-64. PubMed ID: 8625208
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of [3H]-thymidine labelling index and monoclonal antibody Ki-67 in non-Hodgkin's lymphomas.
Veneroni S; Costa A; Motta R; Giardini R; Rilke F; Silvestrini R
Hematol Oncol; 1988; 6(1):21-8. PubMed ID: 3343026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
